Trials / Completed
CompletedNCT00474175
Benzocaine Gel Toothache Dose-Response Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 577 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of benzocaine gel products for the relief of toothache and to assess the subject's compliance with proposed label directions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo gel | single dose (less than 1g) of a matching placebo gel |
| DRUG | benzocaine | single dose (less than 1g) of 10% benzocaine gel formulation |
| DRUG | benzocaine | single dose (less than 1g) of 20% benzocaine gel formulation |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2007-05-16
- Last updated
- 2013-02-28
- Results posted
- 2012-01-18
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00474175. Inclusion in this directory is not an endorsement.